Interleukin-11 (IL-11) enhances clonal proliferation of acute myelogenous leukemia cells with strong expression of the IL-11 receptor α chain and signal transducing gp130

[1]  Y. Sonoda,et al.  Human cord blood-derived primitive progenitors are enriched in CD34+c-kit− cells: correlation between long-term culture-initiating cells and telomerase expression , 1998, Leukemia.

[2]  谷向 茂厚.  Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro , 1998 .

[3]  K. Yasukawa,et al.  Simultaneous activation of signals through gp130, c-kit, and interleukin-3 receptor promotes a trilineage blood cell production in the absence of terminally acting lineage-specific factors. , 1997, Blood.

[4]  F. Appelbaum,et al.  Long‐term survival after chemotherapy for acute myeloid leukemia , 1997, Cancer.

[5]  D. Donaldson,et al.  Recombinant human interleukin-11 directly promotes megakaryocytopoiesis in vitro. , 1997, Blood.

[6]  L. Ailles,et al.  Detection and characterization of primitive malignant and normal progenitors in patients with acute myelogenous leukemia using long-term coculture with supportive feeder layers and cytokines. , 1997, Blood.

[7]  T. Watanabe,et al.  Pharmacokinetics of recombinant human interleukin-11 (rhIL-11) in healthy male subjects. , 1997, British journal of clinical pharmacology.

[8]  W. Piacibello,et al.  Expression of type III receptor tyrosine kinases FLT3 and KIT and responses to their ligands by acute myeloid leukemia blasts. , 1996, Leukemia.

[9]  T. Martin,et al.  The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures , 1996, The Journal of experimental medicine.

[10]  G. Rosen,et al.  A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. , 1996, Blood.

[11]  W. McCaskill-Stevens,et al.  A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. , 1996, Blood.

[12]  S. Kimura,et al.  Primary acute myeloid leukemia cells negative for c-kit receptor protein expression do not proliferate in vitro in response to colony-stimulating factors. , 1996, Leukemia.

[13]  T. Naoe,et al.  Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  R. Bataille,et al.  Molecular cloning of two isoforms of a receptor for the human hematopoietic cytokine interleukin-11. , 1995, Blood.

[15]  S. Ferrari,et al.  Interleukin‐11 (IL‐11) acts as a synergistic factor for the proliferation of human myeloid leukaemic cells , 1995, British journal of haematology.

[16]  F. Mandelli,et al.  Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. , 1995, The New England journal of medicine.

[17]  S. Nakagawa,et al.  Synergistic actions of stem cell factor and other burst-promoting activities on proliferation of CD34+ highly purified blood progenitors expressing HLA-DR or different levels of c-kit protein. , 1994, Blood.

[18]  H. Ogawa,et al.  Expression of the interleukin-6 (IL-6), IL-6 receptor, and gp130 genes in acute leukemia. , 1994, Blood.

[19]  K. Itoh,et al.  Development of a tissue culture assay system for Campylobacter jejuni cytotoxin and the influence of culture conditions on cytotoxin production. , 1994, Journal of medical microbiology.

[20]  H. Mckenna,et al.  Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells. , 1994, Blood.

[21]  J. Leonard,et al.  Recombinant human interleukin-11 stimulates multilineage hematopoietic recovery in mice after a myelosuppressive regimen of sublethal irradiation and carboplatin. , 1994, Blood.

[22]  S. Akira,et al.  Cytokine signal transduction , 1994, Cell.

[23]  小林 祥子.  Interleukin-11 acts as an autocrine growth factor for human megakaryoblastic cell lines , 1994 .

[24]  N. Nara,et al.  Prognostic significance of the blast self‐renewal capacity in patients with acute myeloid leukemia , 1994, Cancer.

[25]  U. Testa,et al.  Autologous stem cell transplantation: sequential production of hematopoietic cytokines underlying granulocyte recovery. , 1993, Cancer research.

[26]  H. Broxmeyer,et al.  In vivo effects of recombinant interleukin-11 on myelopoiesis in mice. , 1993, Blood.

[27]  I. Touw,et al.  Hematopoietic growth factors and their receptors in acute leukemia. , 1993, Blood.

[28]  R. Haas,et al.  Increased serum levels of granulocyte colony-stimulating factor after autologous bone marrow or blood stem cell transplantation. , 1993, Experimental hematology.

[29]  T. Hoang,et al.  Effects of interleukin-11 on the proliferation and cell cycle status of myeloid leukemic cells. , 1993, Blood.

[30]  T. Saito,et al.  Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[31]  K. Anderson,et al.  Lack of a role of interleukin 11 in the growth of multiple myeloma. , 1992, Leukemia research.

[32]  K. Oshimi,et al.  Interleukin-11 enhances human megakaryocytopoiesis in vitro. , 1992, Blood.

[33]  M. Kawakita,et al.  Synergistic effects of interleukin 3 and interleukin 11 on murine megakaryopoiesis in serum-free culture. , 1992, Experimental hematology.

[34]  M. Ogawa,et al.  Direct and synergistic effects of interleukin 11 on murine hemopoiesis in culture. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Ogawa,et al.  Synergistic interactions between interleukin-11 and interleukin-4 in support of proliferation of primitive hematopoietic progenitors of mice. , 1991, Blood.

[36]  David A. Williams,et al.  Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Andreeff,et al.  Kinetic rationale for cytokine-induced recruitment of myeloblastic leukemia followed by cycle-specific chemotherapy in vitro. , 1990, Leukemia.

[38]  N. Nara,et al.  Autocrine growth mechanisms of the progenitors of blast cells in acute myeloblastic leukemia. , 1989, Blood.

[39]  S. Asano,et al.  Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. , 1989, Blood.

[40]  M. Kosaka,et al.  Isolation and storage of peripheral blood hematopoietic stem cells for autotransplantation into children with cancer. , 1989, Blood.

[41]  J. Griffin,et al.  Clonogenic cells in acute myeloblastic leukemia. , 1986, Blood.

[42]  D. Tritchler,et al.  The sensitivity to cytosine arabinoside of the blast progenitors of acute myeloblastic leukemia. , 1986, Blood.

[43]  G Flandrin,et al.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.

[44]  M. Taniwaki,et al.  A variant 15;17 translocation in a patient with acute promyelocytic leukemia. , 1985, Cancer genetics and cytogenetics.

[45]  E. McCulloch,et al.  The contribution of blast cell properties to outcome variation in acute myeloblastic leukemia (AML). , 1982, Blood.

[46]  M. Minden,et al.  Self-renewal in culture of proliferative blast progenitor cells in acute myeloblastic leukemia. , 1979, Blood.